![Philip Frerichs](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Philip Frerichs formerly worked at Wölbern Private Equity GmbH, as Managing Director from 2009 to 2014.
Anciens postes connus de Philip Frerichs
| Sociétés | Poste | Fin |
|---|---|---|
Wölbern Private Equity GmbH
 Wölbern Private Equity GmbH Investment ManagersFinance Wölbern-PE is an active manager which invests across the buyout, venture capital and mezzanine segments, both directly and indirectly. Their multi-manager strategies cover buy-outs across sectors as well as venture capital investments in specific industries, namely life sciences and clean technology. Buyouts investments use a purely fund-of-fund approach while the sector funds follow a hybrid strategy mixing direct and indirect investments. In terms on buyouts, Wölbern-PE focuses on Western Europe and the US, investing between EUR 5 and 15 million per fund, for a total of EUR 20 to 30 million annually across three to five transactions. They target funds which are EUR 500 million to 2 billion in size, managed by cohesive teams with a successful track record in their chosen field. They may invest in first-time funds except when raised by first-time managers. Direct investments target innovative companies in sectors including biotechnology, pharmacology, medical technology, diagnostics, health care and cleantech (power, water, materials and transport). Wölbern-PE typically exits investments through trade sales and IPOs. | Membre du Comité d'Investissement | 02/06/2014 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
4
Relations au 1er degré
1
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Wölbern Private Equity GmbH
Wölbern Private Equity GmbH Investment ManagersFinance Wölbern-PE is an active manager which invests across the buyout, venture capital and mezzanine segments, both directly and indirectly. Their multi-manager strategies cover buy-outs across sectors as well as venture capital investments in specific industries, namely life sciences and clean technology. Buyouts investments use a purely fund-of-fund approach while the sector funds follow a hybrid strategy mixing direct and indirect investments. In terms on buyouts, Wölbern-PE focuses on Western Europe and the US, investing between EUR 5 and 15 million per fund, for a total of EUR 20 to 30 million annually across three to five transactions. They target funds which are EUR 500 million to 2 billion in size, managed by cohesive teams with a successful track record in their chosen field. They may invest in first-time funds except when raised by first-time managers. Direct investments target innovative companies in sectors including biotechnology, pharmacology, medical technology, diagnostics, health care and cleantech (power, water, materials and transport). Wölbern-PE typically exits investments through trade sales and IPOs. | Finance |
